-
Register Now
-
Registration for this event is currently not available. For more information, please email support or call the Special Services number listed below.
-
Download Materials
Special Services
If you require special assistance to attend this event, please email Nathalie Dietrich at Nathalie.Dietrich@uky.edu .
An Equal Opportunity University.
Speakers
Frederick Altice, Lydia Barakat, Michelle Collins-Ogle, Saritha Gomadam, Marwan Haddad, Jon Hourigan, Hermione Hurley, Christopher Hurt, Jeffrey Lennox, Emily McKenzie, Kathleen McMannus, Susanna Naggie, Nathanial Nolan, Elizabeth Novick, Suman Srinivasa, Melanie Thompson, Nicholas Van Sickels
Frederick Altice, MD
Professor of Medicine, Epidemiology and Public Health
Director of Clinical and Community Research
Yale University School of Medicine and School of Public Health
New Haven, Connecticut
Frederick (Rick) L. Altice, MD is a professor of Medicine, Epidemiology and Public Health and is a clinician, clinical epidemiologist, intervention and implementation science researcher at Yale University School of Medicine and School of Public Health. Dr. Altice’s primary research focuses on interventions and implementation science at the interface between infectious diseases and addiction and he has conducted research in several global health settings. He also has a number of projects working in the criminal justice system, including transitional programs addressing infectious diseases, medications for opioid use disorder (methadone, buprenorphine, extended release naltrexone), mental illness, homelessness and social instability. Specific topics include alcohol, opioid, stimulant and nicotine use disorders on HIV treatment outcomes, HIV and addiction treatment, interface with the criminal justice system, and pharmacokinetic drug interactions between treatment for substance use disorders and antiretroviral and tuberculosis therapy. At a basic level, his research focuses on clinical epidemiology, especially in key populations at risk for HIV (e.g., MSM, TGW, PWID, prisoners, sex workers) and development, adaptation and evaluation of of biomedical and behavioral interventions to improve treatment outcomes. His research, however, has evolved and included development and testing of mobile technologies (mHealth) to intervene with key populations to promote health outcomes. His research is especially concentrated in health services research techniques with a focus on implementation science, seeking to introduce and scale-up evidence-based interventions in numerous contexts. A number of implementation science strategies are underway to examine scale-up of medication-assisted therapies to treat opioid use disorder in community, criminal justice and in primary care settings. Most recently, his work has been augmented through use of decision science techniques to understand and promote patient preferences, including the development of informed and shared decision-making aids. His work has emerged primarily with a global health focus with funded research projects internationally in Malaysia, Ukraine, Moldova, Armenia, Kyrgyzstan, Peru, and Indonesia. He has participated in projects through the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, Centers for Disease Control and Prevention, Substance Abuse and Mental Health Services Agency, Special Projects of National Significance with HRSA, and the Center for Substance Abuse Treatment. He is currently also collaborating on projects with the WHO, UNAIDS, USAID, PEPFAR and UNODC. Current internationally funded projects in dedicated research sites that are being conducted in Malaysia, Ukraine, Moldova, Azerbaijan, Armenia, Kyrgyzstan and Peru. His research and training sites in Malaysia (2005), Peru (2010) and Ukraine (2005) are dedicated training and research sites for the Global Health Equity Scholars Fogarty Training Program and the Doris Duke International Fellowship program. He is currently the director for two International Implementation Science Research and Training Centers with collaborations between Yale University and the University of Malaya and Sichuan University.
Lydia Barakat, MD, FIDSA, AAHIVS
Associate Chair, DOM Ambulatory Clinical Affairs
Director, Yale Center for Infectious Diseases
Program Director, Yale HIV Primary Care Track
PI, New England AIDS Education & Training Center, Connecticut Site
Associate Professor of Medicine
Section of Infectious Disease
Yale School of Medicine
New Haven, Connecticut
Dr. Lydia Aoun Barakat, MD is the Medical Director of the Yale Center for Infectious Diseases and she oversees the infectious diseases ambulatory services at YNHH and Yale Medicine, including the care of over 1,500 patients living with or at risk of HIV, general infectious diseases, and transplant infectious disease.
Dr. Barakat’s career is highlighted by her commitment to improving the care for people with HIV and aging with HIV. She has received and contributed to multiple HRSA and CDC grants that are dedicated to the mission of serving the people living with HIV/AIDS and require a long-term vision in accomplishing a high standard quality of care as well as a focus on outcome measures.
Dr. Barakat is a leader in Quality Improvement in HIV care and served as member on several local and national committees dedicated to improving HIV Quality.
Michelle Collins-Ogle, MD, FAAP, FPIDS, AAHIVS
Medical Director
Montefiore Adolescent and Youth Sexual-health Clinic (MAYS)
Associate Professor of Pediatrics
Pediatric Infectious Diseases
Children Hospital at Montefiore
Einstein College of Medicine.
Bronx, New York
Dr. Michelle Collins-Ogle is a Pediatric Infectious Disease and Adolescent Medicine attending. Dr. Ogle has committed the majority of her career to providing comprehensive medical care to infants, children, adolescents and adults living with HIV / AIDS. She provides comprehensive gender affirming care for transgender and nonbinary pediatric and adolescents including those with HIV. She also provides prevention, diagnosis and treatment of sexually transmitted infections including HIV in at- risk adolescents. Dr. Ogle is the Medical Director of the Montefiore Adolescent and Youth Sexual-health Clinic at Children’s Hospital at Montefiore in the Bronx.
Dr. Collins-Ogle is Vice-Chair of the Board of Directors for the American Academy of HIV Medicine, and Vice Chair of the Infectious Disease Society of America’s Committee for Inclusion Diversity and Equity. She is a member of the Ryan White Medical Provider’s Coalition Steering Committee and also proudly served as a member of the Presidential Advisory Council on HIV/AIDS during the Obama Administration.
Saritha Gomadam, DO
Medical Officer
Community Health Services
Richmond, Virginia
Dr Gomadam joined Virginia Department of Health (VDH) in 2023 as the Medical Director for Richmond Henrico Health Districts (RHHD) leading the tuberculosis program, and providing oversight for other programs like STI, and Newcomer health. In august of 2024, she joined the Community Health Services as Medical Officer at VDH. In her current role, apart from providing clinical leadership to health districts lead by non- physician health directors and being a consultant for tuberculosis and other infectious diseases, she serves as a community resource on communicable disease issues and health risk reduction. Together with an interdisciplinary team, efforts are directed towards community assessment and health education, program design, program evaluation, resource allocation, quality of patient care, and inter-agency organization of health-related activities.
Marwan Haddad, MD, MPH, AAHIVS
Medical Director of the Center for Key Populations
Community Health Center, Inc. (CHCI)
Middletown, Connecticut
Marwan Haddad is currently the Medical Director of the Center for Key Populations at Community Health Center, Inc. (CHCI), one of the largest federally qualified health centers in the nation. The Center for Key Populations is the first center of its kind focused on engaging populations who traditionally experience barriers to comprehensive and respectful care secondary to stigma and discrimination. The Center brings together under one roof healthcare, training, research, and advocacy for the LGB (Lesbian, Gay, Bisexual) and Transgender communities, people who use drugs, the homeless and those experiencing housing instability, and the recently incarcerated. The Center oversees the HIV, Hepatitis C (HCV), Substance Use and Medication Assisted Treatment (MAT), Healthcare for the Homeless, and Sexually Transmitted Diseases programs among others at CHCI. Dr. Haddad joined CHCI in July 2006.
He received his Bachelor of Arts degree from Harvard University and his medical degree from McGill University. He completed his family medicine residency at University of Toronto and obtained his Masters in Public Health from Johns Hopkins University. He is board certified in Family Medicine. He is certified by the American Academy of HIV Medicine as an HIV specialist. He was also the recipient of the 2011 Primary Care Leadership Award presented by the Connecticut Center for Primary Care and was named Physician Health Care Hero of 2018 by the Hartford Business Journal. Dr. Haddad is an Assistant Clinical Professor of Family Medicine at Quinnipiac University. He currently serves as Chair-Elect of the HIV Medicine Association (HIVMA).
Since January 2012, Dr. Haddad has led the CHCI Weitzman ECHO HIV, HCV, and MAT programs which expand the integration of these programs not only within CHCI but nationwide. This model of care utilizes didactic and case-based learning via video conferences with medical providers, offering ongoing support, consultation and guidance to aid in delivering care to the HIV, HCV, and opioid-using populations. Dr. Haddad also provides technical assistance support to other health centers in setting up and enhancing integrated MAT programs across the country. Moreover, he has taught and lectured at state and national conferences on HIV, HCV, MAT and substance use management, and integrated care. He has published research on the integration of MAT in community health centers examining both substance use as well as primary care outcomes. He also has and continues to serve internationally as a consultant on HIV, HCV, opioid use disorder, integrated care, and virtual distance learning in Lesotho, Ukraine, Uganda, Jamaica, and Malaysia.
Jon Hourigan, MD, FACS, FASCRS
Associate Professor of Surgery, Division of Colon and Rectal Surgery
University of Kentucky College of Medicine
UK Markey Cancer Center
Lexington, Kentucky
Jon Hourigan, MD was born and raised in Bowling Green, Kentucky. He attended medical school at East Tennessee State University and completed General Surgery residency at the University of Tennessee. He then completed training in Colon and Rectal Surgery at Michigan State University. He is board-certified in both General Surgery and Colon and Rectal Surgery.
Dr. Hourigan’s clinical interests include the comprehensive treatment of colon cancer and rectal cancer, surgical management of inflammatory bowel disease and diverticulitis, and the treatment of benign anorectal disorders. He is an expert in both traditional and minimally invasive approaches for colon and rectal diseases.
Hermione Hurley, MD
Infectious Disease, Addiction Medicine Physician
Denver Health and Hospital Authority, Denver, Colorado
Assistant Professor of Medicine
University of Colorado, Aurora, Colorado
Denver, Colorado
Hermione Hurley is an Assistant Professor at University of Colorado, working as an Infectious Disease and Addiction Medicine physician at Denver Health. Her interest in combining care for ID and substance was prompted by observing poor health outcomes for people after release from incarceration back into the community. Her position is supported by both Psychiatry and Medicine enabling her to treat ID in methadone clinics, and provide medical care for substance use in the ID clinic for people living with HIV.
Christopher Hurt, MD, FIDSA
Professor of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Christopher B. Hurt, MD is an Associate Professor of Medicine in the Institute for Global Health and Infectious Diseases at the University of North Carolina at Chapel Hill (UNC). He received his medical degree from the University of Florida in 2003, completed his internal medicine training at Brown University, and then came to UNC for fellowship training in infectious diseases in 2006. He has been a faculty member in the UNC School of Medicine since 2010 and has directed the North Carolina AETC site since the summer of 2019.
Jeffrey Lennox, MD, FIDSA
Chief of Internal Medicine
Grady Memorial Hospital
Emory University School of Medicine
Atlanta, Georgia
Dr. Jeffrey Lennox received his MD from the University of Colorado, then completed training in Internal Medicine and Infectious Diseases at Walter Reed Hospital in Washington DC. He joined the Emory faculty in 1994 and served as the Grady IDP Medical Director until 2009. He is currently the Emory Internal Medicine service chief for Grady. His main interest is in improving HIV care and in testing longer-acting HIV therapies.
Emily McKenzie, DSW, CSW, CCM
Community Engagement Coordinator
Kentucky Association of Sexual Assault
Programs (KASAP)
Frankfort, Kentucky
Emily McKenzie is the Community Engagement Coordinator at the Kentucky Association of Sexual Assault Programs (KASAP). Emily holds a Doctorate in Social Work from the University of Kentucky College of Social Work and is a Certified Social Worker (CSW). She has over twelve years' experience in anti-violence work. Emily began as a volunteer before serving on staff at a regional sexual violence resource center. She then went on to work at the University of Kentucky Violence Intervention and Prevention Center, working
with student survivors of interpersonal violence. Emily has served on multiple community coalition boards, fostering relationships with community partners and inviting others into the movement to end sexual violence. In her current role at KASAP, she has the opportunity to expand this work across the state.
Kathleen McMannus, MD, MSCR, FIDSA
Associate Professor of Medicine
Division of Infectious Diseases & International Health
University of Virginia
Charlottesville, Virginia
Dr. Kathleen McManus, MD is an Associate Professor of Medicine at the University of Virginia (UVA) in the Division of Infectious Diseases and International Health. She joined the UVA faculty as a physician-scientist in summer 2017 with a research award from the Translational Health Research Institute of Virginia. As a clinician, Dr. McManus sees patients in the UVA Ryan White HIV clinic, and she attends on the Infectious Diseases inpatient consult team. She is the Medical Director of the UVA Ryan White HIV Clinic and the Principal Investigator for the Ryan White Program Grants. Dr. McManus is a member and previous co-chair of the HIV Medical Association's national Ryan White HIV Medical Providers Coalition Steering Committee.
Susanna Naggie, MD, MHS
Professor of Medicine, Infectious Diseases
Vice Dean for Clinical and Translational Research
Director, Duke Clinical and Translational Sciences Institute
Duke School of Medicine
Durham, North Carolina
Dr. Susanna Naggie completed her undergraduate degrees in chemical engineering and biochemistry at the University of Maryland, College Park, and her medical education at Johns Hopkins School of Medicine. She conducted her internal medicine and infectious diseases fellowship training at Duke University Medical Center, where she also served as Chief Resident. She joined the faculty at the Duke School of Medicine in 2009. She is a Professor of Medicine and currently holds appointments at the Duke University School of Medicine, the Duke Clinical Research Institute, and the Durham Veterans Affairs Medical Center. Dr. Naggie is a clinical investigator with a focus on clinical trials in infectious diseases and translational research in HIV and liver disease. She is a standing member of the DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents and the CDC/NIH/IDSA-HIVMA Opportunistic Infections Guideline. She is the Vice Dean for Clinical and Translational Research and Director for the Duke Clinical and Translational Sciences Institute.
Nathanial Nolan, MD, MPH, MPHE
Instructor in Medicine
Division of Infectious Diseases
VA St. Louis Health Care
Washington University School of Medicine
St Louis, Missouri
Nathanial Nolan, MD is an instructor in Medicine at the Veteran’s Health Administration in St. Louis.
Dr. Nolan specializes in clinical medicine and education, with a special focus on marginalized populations, including patients who use drugs and patients who are unhoused. His research has focused on infection prevention in homeless shelters and managing infections in people admitted with complications of injection drug use.
He also has a special interest in digital education and was one of the founding members of the ID Fellows Network. He attends on the general ID service and medicine teaching service, teaching fellows, residents, and students. He also sees patients in a general ID clinic and has an HIV clinic.
He is currently mentoring fellows, residents, and/or students in medical education.
Elizabeth Novick, MD
Clinical Assistant Professor
Thomas Jefferson University
Philadelphia, Pennsylvania
Dr. Elizabeth E. Novick (Edwards) is an infectious disease specialist in Philadelphia, Pennsylvania and is affiliated with Thomas Jefferson University Hospitals-Jefferson Health. She received her medical degree from Georgetown University School of Medicine in 2016.
Suman Srinivasa, MD
Assistant Professor of Medicine
Harvard Medical School
Endocrinologist
Massachusetts General Hospital
Boston, Massachusetts
Dr. Suman Srinivasa is faculty at Harvard Medical School, clinician in the Neuroendocrine and Pituitary Tumor Clinical Center, and physician investigator in the Metabolism Unit at the Massachusetts General Hospital. She serves as Co-Director of the MIRACLEs HIV program (Metabolic Investigations Researching Adipose and Cardiovascular Health in HIV). Her clinical research trajectory has concentrated on exploring mechanisms and treatment strategies for inflammation and cardiometabolic disease in HIV. Awards in recognition of her work include the NIH R01, NIH K23, Harvard Catalyst Medical Research Investigator Training Award, Gilead Research Scholars in HIV, and Nutrition and Obesity Research Center at Harvard Pilot and Feasibility Grant. She is recipient of The Endocrine Society Early Investigator Award and the CROI Young Investigator Scholarship, as well as a two-time recipient of the Women in Endocrinology Young Investigator Award.
Melanie Thompson, MD
Principal Investigator and Executive Director
AIDS Research Consortium of Atlanta (ARCA)
Physician of Internal Medicine
Thacker and Thompson MD PC
Piedmont Clinic
Atlanta, Georgia
Melanie Thompson, MD, co-chairs the HIVMA/IDSA HIV Primary Care Guidance Panel and serves on the International Antiviral Society-USA Antiretroviral Therapy Guidelines Panel. She is a past chair of HIVMA and now serves on its Leadership Development Committee. She currently chairs the Ryan White Part A Comprehensive Planning Committee for Metropolitan Atlanta and serves on the mayor of Atlanta’s LGBTQ Advisory Committee. In 1988, she founded the AIDS Research Consortium of Atlanta, and, as the consortium’s principal investigator, led over 400 studies in the areas of HIV, sexually transmitted infections and viral hepatitis, contributing to the Food and Drug Administration licensure of over 40 drugs for HIV treatment and prevention. She has been a clinical researcher, provider of HIV clinical care and policy advocate for over 35 years and maintains an HIV primary care practice in Atlanta. She is a passionate advocate for social justice and health equity.
Nicholas Van Sickels, MD
Associate Professor
Associate Division Chief
Division of Infectious Diseases
University of Kentucky
Lexington, Kentucky
Dr. Van Sickels grew up in San Antonio, Texas. After graduating from the University of Texas, Austin, he was accepted into the University of Kentucky College of Medicine in Lexington, Kentucky. Following graduation, he was accepted into internal medicine residency at Tulane University in New Orleans, Louisiana. After his chief resident year, he remained at Tulane for Infectious Diseases Fellowship, and transitioned to become a faculty member in the infectious diseases section through 2016. He then served as the Chief Medical Officer at CrescentCare, a Federally Qualified Health Center in New Orleans, through 2022. In August of 2022 he returned to Lexington, where he is now an Associate Professor in the Department of Internal Medicine, Division of Infectious Diseases, at the University of Kentucky.
